Business Wire
BusinessFTC issues civil subpoenas to OpenAI and Anthropic in consumer-protection probe, spotlighting regulatory risk for Microsoft and other major AI backersThe Apex TimesBusinessSkydance steadies after merger-era drop, Disney firms and Netflix eases lower in afternoon tradingThe Apex TimesBusinessBlackRock files a bitcoin ETF structure aimed at limiting losses and capping gains using optionsThe Apex TimesBusinessModerna shares jump 7% as melanoma vaccine data in Madrid draws attention; Bristol Myers and Pfizer also edge higherThe Apex TimesBusinessChevron seeks stake shift in Iraq oil field tied to Russian influence, as U.S. pressures the status quoThe Apex TimesBusinessCaterpillar vs. Deere in the data-center buildout debate: what investors are weighingThe Apex TimesBusinessBraze shares surge after Salesforce agrees to buy the marketing software company for $47The Apex TimesBusinessAlaska Airlines names CVS Health executive for newly created technology and AI roleThe Apex TimesBusinessEli Lilly’s pediatric ulcerative colitis trial results put Omvoh back in focus for investors, but full details remain limitedThe Apex TimesBusinessGeneral Motors shares fall about 6% even after a reported earnings beat, as investors focus on the narrower outlook rangeThe Apex TimesBusinessWalmart ties Walmart+ and Sam’s Club into a single $120-a-year membership bundleThe Apex TimesBusinessBoeing and Microsoft collaboration on an AI “dataliner” platform draws analyst attention, lifting BMO’s Microsoft targetThe Apex TimesBusinessFTC issues civil subpoenas to OpenAI and Anthropic in consumer-protection probe, spotlighting regulatory risk for Microsoft and other major AI backersThe Apex TimesBusinessSkydance steadies after merger-era drop, Disney firms and Netflix eases lower in afternoon tradingThe Apex TimesBusinessBlackRock files a bitcoin ETF structure aimed at limiting losses and capping gains using optionsThe Apex TimesBusinessModerna shares jump 7% as melanoma vaccine data in Madrid draws attention; Bristol Myers and Pfizer also edge higherThe Apex TimesBusinessChevron seeks stake shift in Iraq oil field tied to Russian influence, as U.S. pressures the status quoThe Apex TimesBusinessCaterpillar vs. Deere in the data-center buildout debate: what investors are weighingThe Apex TimesBusinessBraze shares surge after Salesforce agrees to buy the marketing software company for $47The Apex TimesBusinessAlaska Airlines names CVS Health executive for newly created technology and AI roleThe Apex TimesBusinessEli Lilly’s pediatric ulcerative colitis trial results put Omvoh back in focus for investors, but full details remain limitedThe Apex TimesBusinessGeneral Motors shares fall about 6% even after a reported earnings beat, as investors focus on the narrower outlook rangeThe Apex TimesBusinessWalmart ties Walmart+ and Sam’s Club into a single $120-a-year membership bundleThe Apex TimesBusinessBoeing and Microsoft collaboration on an AI “dataliner” platform draws analyst attention, lifting BMO’s Microsoft targetThe Apex TimesBusinessFTC issues civil subpoenas to OpenAI and Anthropic in consumer-protection probe, spotlighting regulatory risk for Microsoft and other major AI backersThe Apex TimesBusinessSkydance steadies after merger-era drop, Disney firms and Netflix eases lower in afternoon tradingThe Apex TimesBusinessBlackRock files a bitcoin ETF structure aimed at limiting losses and capping gains using optionsThe Apex TimesBusinessModerna shares jump 7% as melanoma vaccine data in Madrid draws attention; Bristol Myers and Pfizer also edge higherThe Apex TimesBusinessChevron seeks stake shift in Iraq oil field tied to Russian influence, as U.S. pressures the status quoThe Apex TimesBusinessCaterpillar vs. Deere in the data-center buildout debate: what investors are weighingThe Apex TimesBusinessBraze shares surge after Salesforce agrees to buy the marketing software company for $47The Apex TimesBusinessAlaska Airlines names CVS Health executive for newly created technology and AI roleThe Apex TimesBusinessEli Lilly’s pediatric ulcerative colitis trial results put Omvoh back in focus for investors, but full details remain limitedThe Apex TimesBusinessGeneral Motors shares fall about 6% even after a reported earnings beat, as investors focus on the narrower outlook rangeThe Apex TimesBusinessWalmart ties Walmart+ and Sam’s Club into a single $120-a-year membership bundleThe Apex TimesBusinessBoeing and Microsoft collaboration on an AI “dataliner” platform draws analyst attention, lifting BMO’s Microsoft targetThe Apex TimesBusinessFTC issues civil subpoenas to OpenAI and Anthropic in consumer-protection probe, spotlighting regulatory risk for Microsoft and other major AI backersThe Apex TimesBusinessSkydance steadies after merger-era drop, Disney firms and Netflix eases lower in afternoon tradingThe Apex TimesBusinessBlackRock files a bitcoin ETF structure aimed at limiting losses and capping gains using optionsThe Apex TimesBusinessModerna shares jump 7% as melanoma vaccine data in Madrid draws attention; Bristol Myers and Pfizer also edge higherThe Apex TimesBusinessChevron seeks stake shift in Iraq oil field tied to Russian influence, as U.S. pressures the status quoThe Apex TimesBusinessCaterpillar vs. Deere in the data-center buildout debate: what investors are weighingThe Apex TimesBusinessBraze shares surge after Salesforce agrees to buy the marketing software company for $47The Apex TimesBusinessAlaska Airlines names CVS Health executive for newly created technology and AI roleThe Apex TimesBusinessEli Lilly’s pediatric ulcerative colitis trial results put Omvoh back in focus for investors, but full details remain limitedThe Apex TimesBusinessGeneral Motors shares fall about 6% even after a reported earnings beat, as investors focus on the narrower outlook rangeThe Apex TimesBusinessWalmart ties Walmart+ and Sam’s Club into a single $120-a-year membership bundleThe Apex TimesBusinessBoeing and Microsoft collaboration on an AI “dataliner” platform draws analyst attention, lifting BMO’s Microsoft targetThe Apex Times
Back to front
Analyst-leaning model predicts Netflix shares could cross $100 on Sept. 18, 2026
The Apex Times

THE APEX TIMES

Business/The Apex Times/Jun 20, 11:51 AM EDT

Analyst-leaning model predicts Netflix shares could cross $100 on Sept. 18, 2026

The forecast, flagged by 24/7 Wall St., projects Netflix (NFLX) will reach the $100 level based on a proprietary projection, while offering no new company disclosures.

Netflix shares were trading around $76.96 as of June 20, 2026, and a new market call circulating through 24/7 Wall St. argues that the stock could cross the psychologically important $100 threshold on September 18, 2026.

The projection does not claim a specific corporate catalyst tied to that date. Instead, it is framed as a timing forecast generated by a proprietary model, with the $100 move presented as an outcome the model expects rather than a milestone Netflix itself has guided.

For investors, the $100 level matters mostly because of how markets interpret round-number prices, options positioning, and sentiment. When a stock approaches a headline level, analysts and traders often revisit assumptions about growth, margins, and the durability of subscriber economics.

Netflix is currently a widely followed media and technology platform, so any share-price forecast can quickly become a talking point even without incremental filings or guidance. However, the article’s central contribution is the projection itself, not an update to revenue, subscriber metrics, or cost structure.

Netflix has not, in the material tied to this forecast, disclosed any new program, earnings framework, or operational plan that connects directly to a Sept. 18 crossing. The Netflix newsroom page continues to serve as the company’s channel for product and business updates, but there is nothing in the forecast-linked post that ties those updates to this specific date.

Sector context is important. In streaming and broader technology markets, share-price paths tend to respond to shifts in expectations for engagement, pricing power, competition, and advertising or international growth. Even so, a date-specific target derived from a model should be treated as conditional, not as an announcement of future results.

The main limitation is that the forecast post does not provide enough detail in the information available here to verify what inputs drive the model’s timing, how sensitive the estimate is to changes in assumptions, or what probability range surrounds the predicted crossing.

Still, the episode underscores how market participants use simple thresholds as reference points for complex expectations. What to watch next is whether Netflix’s next set of results and management commentary, along with market moves in streaming multiples, bring the stock’s path closer to or further from the projected level.

Why It Matters

  • A date-specific stock forecast can influence market attention, even without new fundamental information.
  • Round-number levels like $100 often affect trading behavior, options activity, and sentiment.
  • The credibility of timing predictions depends on how assumptions evolve, which may shift with earnings and competitive dynamics.
  • If the projection gains traction, it could raise scrutiny of Netflix’s near-term performance expectations heading into upcoming reporting periods.

Sources

Key Facts

  • As of June 20, 2026, Netflix was reported to trade at about $76.96.
  • 24/7 Wall St. cited a proprietary model projection that Netflix could cross $100 on September 18, 2026.
  • The $100 level is presented as a psychologically important threshold rather than a company-stated target.
  • The forecast is tied to a prediction, not to new Netflix disclosures in the cited post.
  • Netflix’s official newsroom is where the company typically publishes product and business updates, but no direct Sept. 18 link is described in the available material.

Technology Related

Analyst-leaning model predicts Netflix shares could cross $100 on Sept. 18, 2026 | The Apex Times